ATP Hydrolysis by a CFTR Domain: Pharmacology and Effects of G551D Mutation
- 10 May 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 271 (2) , 518-525
- https://doi.org/10.1006/bbrc.2000.2659
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Control of CFTR Channel Gating by Phosphorylation and Nucleotide HydrolysisPhysiological Reviews, 1999
- Expression and Characterization of the NBD1-R Domain Region of CFTR: Evidence for Subunit−Subunit InteractionsBiochemistry, 1998
- The cystic fibrosis transmembrane conductance regulator and ATPCurrent Opinion in Cell Biology, 1997
- Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).Journal of Bioenergetics and Biomembranes, 1997
- A recombinant peptide model of the first nucleotide‐binding fold of the cystic fibrosis transmembrane conductance regulator: Comparison of wild‐type and ΔF508 mutant formsProtein Science, 1996
- The First Nucleotide Binding Fold of the Cystic Fibrosis Transmembrane Conductance Regulator Can Function as an Active ATPaseJournal of Biological Chemistry, 1995
- Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.Journal of Clinical Investigation, 1994
- ATPase activity and ATP/ADP‐induced conformational change in the soluble domain of the bacterial protein translocator HlyBMolecular Microbiology, 1993
- Intrinsic anion channel activity of the recombinant first nucleotide binding fold domain of the cystic fibrosis transmembrane regulator protein.Proceedings of the National Academy of Sciences, 1992
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989